QUOTED. Scott Whitaker.
Executive Summary
Industry representatives like AdvaMed president Scott Whitaker have criticized the US Medicare agency’s decision to withdraw a rule that would give temporary automatic coverage to breakthrough devices.
“It’s unfortunate for patients across the country that the administration has decided to reject a rule to allow Medicare patients immediate access to breakthrough medical innovations.” – Scott Whitaker, president, AdvaMed
- Find out more: CMS Dashes Industry Hopes For MCIT Rule Any Time Soon
Click here for a free trial of Medtech Insight